The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes

To determine whether the use of glyburide is associated with an increased risk of cancer compared with the use of other second-generation sulfonylureas among patients with type 2 diabetes. The U.K. Clinical Practice Research Datalink was used to conduct a cohort study among 52,600 patients newly pre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2015-11, Vol.38 (11), p.2083-2089
Hauptverfasser:	Tuccori, Marco, Wu, Jennifer W, Yin, Hui, Majdan, Agnieszka, Azoulay, Laurent
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cancer Cohort Studies Comparative analysis Diabetes Diabetes Mellitus, Type 2 - drug therapy Female Glyburide - adverse effects Glyburide - therapeutic use Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Male Middle Aged Neoplasms - chemically induced Neoplasms - etiology Prescription drugs Retrospective Studies Risk Factors Sulfonylurea Compounds - adverse effects Sulfonylurea Compounds - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!